Brian Morris | Hypertension | Best Academic Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Dr. Brian Morris | Hypertension | Best Academic Researcher Award

University Of Sydney | Australia

Professor Dr. Brian Morris is a highly respected biomedical scientist and Professor Emeritus at the School of Medical Sciences, University of Sydney, acclaimed for his groundbreaking research in molecular medical sciences, hypertension, and public health. Throughout his distinguished career, he has made substantial contributions to understanding the genetic and molecular foundations of cardiovascular disease and ageing. He has held several prominent academic positions, including Professor of Molecular Medical Sciences and Senior Lecturer in Physiology, and has provided influential leadership in organizing international scientific conferences, such as the first global meeting on the molecular genetics of hypertension. Professor Morris has also served on major national and international research committees, editorial boards, and review panels, and is recognized as an exceptional mentor whose students have gone on to achieve senior positions in academia and industry worldwide. His numerous honors and fellowships from prestigious organizations reflect his exceptional contributions to science and education. With a prolific publication record of 404 documents, his research has received 11,835 citations from 8,579 documents, achieving an h-index of 56. His studies, published in leading journals including Circulation, Nature Genetics, PNAS, and Hypertension, have influenced scientific thought globally. His pioneering patent for the first use of PCR in viral detection further underscores his lasting impact on molecular diagnostics. Through his scientific innovation, academic leadership, and lifelong dedication to advancing knowledge, Professor Morris has made enduring contributions to cardiovascular and molecular health research worldwide.

Profiles: Scopus | Orcid

Featured Publications

Sarman, G., Cox, G., & Morris, B. J. (2025). Critique of “The impact of foot reflexology on postoperative pain and fear in children following circumcision: A randomized controlled trial.” Journal of Pediatric Urology.

Cox, G., & Morris, B. J. (2025). Comments on Fendereski et al., Comparing penile problems in circumcised vs. uncircumcised boys: Insights from a large commercial claims database with a focus on provider type performing circumcision. Journal of Pediatric Surgery.

Chen, R., Donlon, T. A., Morris, B. J., Allsopp, R. C., Willcox, B. J., & Masaki, K. H. (2024). Association of alcohol with lung cancer risk in men with different growth hormone receptor genotypes. Lung Cancer.

Chen, R., Morris, B. J., Donlon, T. A., Nakagawa, K., Allsopp, R. C., Willcox, B. J., Masaki, K. H., & Lipsitz, L. A. (2024). FOXO3 longevity genotype mitigates risk posed by hypertension on incident coronary artery disease in middle-aged men: Kuakini Honolulu Heart Program. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences.

Morris, B. J., & Banerjee, J. (2024). Comment on ‘Changing relationships between HIV prevalence and circumcision in Lesotho’, and ‘Age-incidence and prevalence of HIV among intact and circumcised men: an analysis of PHIA surveys in Southern Africa’. Journal of Biosocial Science.

Morris, B. J., & Klausner, J. D. (2024). Detrimental to public health: Royal Australasian College of Physicians’ recent policy on infant circumcision. Pediatric Research.

Maheshkumar Baladaniya | Cardiac Rehabilitation | Industry Impact Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Maheshkumar Baladaniya | Cardiac Rehabilitation | Industry Impact Award

Neighborhood Physical Therapy PC | United States

Dr. Maheshkumar Baladaniya, PT, MS, DPT, is a highly accomplished and licensed Physical Therapist recognized for his extensive expertise in clinical rehabilitation, healthcare management, and research. Currently serving as Clinical Director at Neighborhood PT PC in New City, NY, he brings a decade of progressive experience in patient care, program leadership, and interdisciplinary coordination. His clinical focus spans pediatric, geriatric, neuro, orthopedic, sports, and cardiopulmonary rehabilitation, where he integrates evidence-based therapeutic approaches to enhance functional recovery and quality of life. Dr. Baladaniya has successfully developed and implemented innovative rehabilitation programs, supervised multidisciplinary teams, and contributed to quality improvement initiatives across clinical settings. He holds a Doctor of Physical Therapy from the University of Montana, USA, a Master of Science in Health Informatics from the American College of Commerce and Technology, VA, and dual Master’s degrees in Physiotherapy (Sports and Neurology) from the National Institute of Medical Science, Jaipur, India, along with a Bachelor’s degree in Physiotherapy from Acharya Institute of Health Sciences, Bangalore, India. In addition to his clinical and leadership roles, Dr. Baladaniya is an active researcher with 24 published documents, 74 citations, and an h-index of 4, underscoring his academic impact and commitment to advancing rehabilitation science. His professional journey reflects dedication to excellence in patient-centered care, clinical innovation, and lifelong learning in physical therapy.

Profiles: Orcid | Google Scholar

Featured Publications

Baladaniya, M. (2024). Epidemiological study on developmental coordination disorder in school-going children. Journal of Pediatrics Research Reviews & Reports.

Baldania, S., & Baladaniya, M. (2024). Heart and lung dysfunction prevention through rehabilitation and physical therapy education: A comprehensive overview. Journal of Cardiology Research Review & Reports.

Baladaniya, M., & Baldania, S. (2024). Intersectionality in neurodevelopmental disorders: A literature review on co-occurrence of autism spectrum disorder and attention-deficit/hyperactivity disorder – Examining therapeutic approaches and interventions. International Journal of Health Sciences.

Baladaniya, M., & Gulrandhe, P. (2024). Shoulder and elbow synergy for lateral epicondylalgia management: A case report. Journal of Clinical and Diagnostic Research.

Baladaniya, M., & Korat, A. S. (2024). The impact of digital technology use on child development: A comprehensive literature review. Journal of Pediatrics Research Reviews & Reports.

Yixin Xu | Cardiovascular Researches | Best Researcher Award 2025

Published on by Cardiology and Cardiovascular Medicine

Dr. Yixin Xu | Cardiovascular Researches | Best Researcher Award

The First Affiliated Hospital of Army Medical University | China

Author Profile

Orcid

Early Academic Pursuits

YiXin Xu began her medical journey at Xinjiang Medical University, where she pursued an undergraduate degree in Clinical Medicine. Her strong academic performance and dedication to patient care inspired her to continue postgraduate studies in Internal Medicine, specializing in cardiovascular medicine. This early pursuit of advanced knowledge built the foundation for her growing expertise in both clinical practice and research.

Professional Endeavors

Her professional development included an internship at the Traditional Chinese Medicine Hospital of Shapingba District in Chongqing City, where she gained valuable clinical exposure. She then undertook standardized resident physician training at the First Affiliated Hospital of Xinjiang Medical University. During this period, she successfully managed patient care, independently handled on-duty responsibilities, and developed expertise in treating conditions such as coronary heart disease, hypertension, and pulmonary hypertension.

Contributions And Research Focus

She has contributed to several important research projects that bridge clinical practice with scientific inquiry. These include investigating the relationship between vitamin D, parathyroid hormone, and circadian rhythms in blood pressure regulation among patients with hypertension. She also participated in the Step-Pre Project and the "iCare-Me" initiative, both of which aim to improve patient outcomes through innovative approaches. Additionally, she contributed to the creation of a predictive model for heart failure in patients with coronary heart disease, based on metabolic biomarkers, highlighting her focus on precision medicine and translational research.

Clinical Expertise

Through her training, she became proficient in both the theoretical and practical aspects of internal medicine. She is skilled in the standardized documentation of medical records, surgical notes, and disease course records. Her technical expertise includes performing essential clinical procedures such as abdominal puncture and bone marrow puncture. These abilities underscore her readiness to practice medicine at a high professional standard.

Impact And Influence

Her dual contributions as a clinician and researcher have positioned her to influence both patient care and the scientific community. By combining clinical experience with data-driven research, she advances understanding in cardiovascular disease while improving strategies for patient management. Her work reflects a commitment to bridging the gap between medical research and real-world healthcare delivery.

Academic Cites

Her scholarly contributions have been acknowledged through participation in collaborative studies and cited within ongoing cardiovascular research initiatives. These academic references reflect her growing influence and recognition within the medical research community.

Legacy And Future Contributions

Looking forward, she aspires to strengthen predictive models for cardiovascular disease and enhance evidence-based treatment protocols. Her career vision includes contributing to global medical research networks, publishing impactful studies, and advancing patient care practices through innovation and collaboration.

Conclusion

YiXin Xu exemplifies the qualities of a dedicated physician and researcher. With her academic excellence, clinical expertise, and meaningful research contributions, she is poised to make significant advancements in cardiovascular medicine. Her commitment to innovation and patient-centered care ensures that she will leave a lasting impact on both clinical practice and medical science.

Notable Publication

"Parathyroid hormone and vitamin D modulate nocturnal blood pressure dipping: a retrospective cohort study in primary hypertension"

Authors: Yixin Xu, Changjiang Deng, Xiaohui Liang
Journal: Clinical and Experimental Hypertension
Year: 2025

Fengxu Yu | Atrial Fibrillation | Best Researcher Award 

Published on by Cardiology and Cardiovascular Medicine

Fengxu Yu | Atrial Fibrillation | Best Researcher Award 

The Affiliated Hospital of Southwest Medical University | China

Author Profile:

Scopus

👨‍⚕️ MR. FENGXU YU – PIONEER IN CARDIOVASCULAR INNOVATION

🎓 EARLY ACADEMIC PURSUITS

Born in January 1976, Professor Fengxu Yu embarked on his medical journey with a strong academic foundation, earning his M.D. and later achieving qualifications as a doctoral supervisor. His passion for cardiovascular science led him to pursue postdoctoral training in France, equipping him with a global perspective and refined clinical research skills. This international exposure laid the groundwork for his future leadership in complex cardiovascular research and surgical practice.

💼 PROFESSIONAL ENDEAVORS

Currently serving as a Professor at The Affiliated Hospital of Southwest Medical University, Dr. Yu holds several distinguished roles:

  • Standing Committee Member, Cardiac Surgery Committee (CAMEA)

  • Committee Member, Heart Valve Committee (CRHA)

  • Vice Chair, Sichuan Thoracic & Cardiac Surgery Association

  • Academic Leader, recognized by the Sichuan Health Commission

  • Member, Asian Heart Valve Society, China Chapter

  • Recipient, Luzhou Top Talent Award

His consistent dedication has cemented his role as a leading figure in thoracic and cardiac surgery across China.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON ATRIAL FIBRILLATION

Dr. Yu’s research endeavors focus on molecular and biomechanical mechanisms in cardiovascular disease, especially atrial fibrillation (AF), atherosclerosis, and aortic dissection. His current areas of exploration include:

  • Non-coding RNAs (e.g., circRNA/ceRNA networks) in AF pathogenesis

  • Application of induced pluripotent stem cells in modeling AF

  • Effects of shear stress on vascular endothelial health and its link to atherosclerosis

Through these efforts, Dr. Yu bridges basic science with clinical relevance, advancing the future of personalized medicine.

📊 IMPACT AND INFLUENCE

As a principal investigator, Dr. Yu has led nearly 20 major research projects funded by provincial and municipal institutions. He has also contributed to 30+ collaborative studies as a lead or co-investigator. His academic output includes over 50 peer-reviewed publications, with 12 articles indexed in SCI journals and 20+ papers in national core journals, showcasing his thought leadership in cardiovascular science.

📚 SELECTED RESEARCH PROJECTS

Some of Dr. Yu’s notable funded projects include:

  • Mechanism of Shear Stress-Downregulated Annexin A1 (2019)

  • circRNA-Regulated ceRNA Networks in AF (2025)

  • Personalized Warfarin Therapy Post-Valve Replacement (2022)

  • Hsa_circ_0025573—miR-133b—MMP9 in AF Pathogenesis (2022)

  • SRB1-Mediated Endothelial Injury in Atherosclerosis (2018)

These projects reflect a multidisciplinary approach to understanding and treating cardiovascular conditions.

🏅 ACADEMIC CITES AND MEMBERSHIPS

Professor Yu actively contributes to national and international academic bodies. His memberships include:

  • CAMEA – Cardiac Surgery Committee

  • CRHA – Heart Valve Committee

  • Sichuan Thoracic & Cardiac Surgery Association

  • Asian Heart Valve Society – China Chapter

These affiliations enhance his visibility in shaping future cardiac surgery standards and innovations.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

Professor Fengxu Yu is a mentor, innovator, and academic leader. His mentorship of graduate students, collaboration with international institutions such as Heidelberg University, and continued work on translational research ensure a legacy of impactful science. As cardiovascular disease remains a global challenge, his pioneering work in non-coding RNA and biomechanical interactions is poised to redefine prevention and treatment strategies.

📑 NOTABLE PUBLICATIONS

"Myocardial infarction serum preconditioning bone marrow mesenchymal stem cell-derived exosomes enhance anti-fibrosis in rat myocardial infarction hearts" 

Authors: Y., Gan, Yang , C., Wang, Changyi , R., Liao, Ruili , ... H., Liu, Hui , Y., Fu, Yong
Journal: Molecular and Cellular Biochemistry.
Year: 2025

"Identification of the optimal reference genes for atrial fibrillation model established by iPSC-derived atrial myocytes" 

Authors: L., Li, Lei , Z., Zhao, Zijuan , Z., Liu, Zihao , ... Y., Nie, Yongmei , F., Yu, Fengxu
Journal: BMC Genomics
Year: 2024

"Postoperative delirium prediction after cardiac surgery using machine learning models" 

Authors: T., Yang, Tan , H., Yang, Hai , Y., Liu, Yan , ... Y., Zhang, Ying , F., Yu, Fengxu
Journal: Computers in Biology and Medicine
Year: 2024

Xianhong Ou | Cardiovascular Pharmacology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Xianhong Ou | Cardiovascular Pharmacology | Best Researcher Award

Christina Antza | Hypertension | Best Research Article Award

Published on by Cardiology and Cardiovascular Medicine

Assist. Prof. Dr. Christina Antza | Hypertension | Best Research Article Award

Assist. Prof. Dr. Christina Antza, 3rd Department of Internal Medicine, Aristotle University of Thessaloniki, Greece

Assist. Prof. Dr. Christina Antza is a specialist in Internal Medicine and Hypertension at the 3rd Department of Internal Medicine, Aristotle University of Thessaloniki, Greece. She holds an M.D., a Ph.D. in blood pressure measurement methods, and an M.Sc. in Research Methodology. Dr. Antza has extensive experience in hypertension, metabolic syndrome, diabetes, and atherosclerosis. She has worked as a researcher, consultant, and medical educator in Greece and the UK. Recognized with multiple awards and fellowships, she actively contributes to international medical research and education, shaping advancements in cardiovascular and metabolic disease management.

AUTHOR PROFILE

Orcid Profile

🎓 EARLY ACADEMIC PURSUITS:

Dr. Christina Antza began her educational journey at the Fifth High-School of Drama (Junior High School) and Third High School of Drama (Senior High School). She then pursued her Medical Degree at Aristotle University of Thessaloniki, Greece (2007-2013), graduating with an impressive 8/10 grade.

Her passion for research and academia led her to further studies, including:

  • Ph.D. in Internal Medicine (2014-2019) – Focused on blood pressure measurement methods and their ability to predict early vascular aging. She earned a Grade A with Distinction under the supervision of Prof. V. Kotsis.
  • Master of Science in Research Methodology in Medicine and Health Science (2016-2018) – Achieved an outstanding 9/10 grade.
  • Research Fellowship (2019-2020) – Conducted clinical and research work in Diabetes Mellitus and Obesity at the University of Birmingham, UK.
  • Postdoctoral Research (2019-2022) – Specialized in Hypertension and Metabolic Syndrome at Aristotle University of Thessaloniki.
  • Internal Medicine Consultant Certification (2021) – Earned after passing rigorous written and oral examinations.

💼 PROFESSIONAL ENDEAVORS:

Dr. Antza has held various prestigious roles in internal medicine, focusing on hypertension, metabolic syndrome, and endocrinology:

  • Scientific Associate (2013-2014) – Engaged in research and clinical practice in hypertension at the 3rd Department of Internal Medicine, Aristotle University of Thessaloniki.
  • Medical Resident (2016-2021) – Trained at Papageorgiou General Hospital, Aristotle University of Thessaloniki.
  • Academic Fellowship in Hypertension & Metabolic Syndrome (2021-2022) – Focused on clinical practice, independent teaching, and research.
  • Internal Medicine Consultant (2021-2023) – Served at Papageorgiou General Hospital and Bioclinic, offering expertise in hypertension, diabetes, and emergency medicine.
  • Assistant Professor of Internal Medicine – Hypertension (2023-Present) – Currently educating future medical professionals and leading research at Aristotle University of Thessaloniki.

Additionally, she has participated as a Subinvestigator in Phase 2 & 3 Clinical Trials, contributing to advancements in hypertension and metabolic disorders.

📚 CONTRIBUTIONS AND RESEARCH FOCUS ON HYPERTENSION:

Dr. Antza has extensively researched hypertension, metabolic syndrome, diabetes, lipid disorders, and vascular aging. Her work has focused on:

  • Blood Pressure Measurement Techniques (Home, Ambulatory, and Clinical).
  • Atherosclerosis and Cardiovascular Risk.
  • Metabolic Syndrome and Obesity-Related Disorders.
  • Diabetes and Endocrine Disorders.

She has been actively involved in research collaborations with leading medical institutions, including Queen Elizabeth Hospital, Birmingham, UK, where she served as an Honorary Observer (2019-2022) in the Endocrinology Department.

🏆 IMPACT AND INFLUENCE:

Dr. Antza’s work has been recognized with numerous awards and fellowships:

  • Young Fellow of the European Atherosclerosis Society (2019-Present).
  • Young Fellow of the European Hypertension Society (2023-Present).
  • Recipient of multiple Investigator Grants & Travel Awards from the European Society of Hypertension (ESH) and European Atherosclerosis Society (EAS).
  • 1st Place Oral Presentation Award – 8th Panhellenic Congress of the Hellenic Atherosclerosis Society (2019).
  • 2nd Clinical Research Award – 9th Panhellenic Congress of the Hellenic Atherosclerosis Society (2020).
  • Young Investigator Fellowship Award – 89th EAS Virtual Congress (2021).

📖 ACADEMIC CITATIONS & SCHOLARSHIPS:

Dr. Antza’s research has been widely cited in medical literature, influencing clinical guidelines in hypertension and metabolic diseases. Her scholarly excellence has earned her:

  • Ph.D. Scholarship from the Hellenic Society of Atherosclerosis (2014-2015).
  • Postdoctoral Research Scholarship from the State Scholarship Foundation (2019-2021).
  • Award from the Medical Sciences Deanery for Ph.D. Research (2020).

🌍 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Christina Antza is poised to make significant future contributions in the diagnosis and management of hypertension, metabolic syndrome, and cardiovascular diseases. Her expertise in clinical research, education, and innovative treatment strategies will continue to shape internal medicine and patient care.

Her future goals include:
✔ Expanding research on hypertension-related complications and vascular aging.
✔ Leading international collaborations in cardiovascular and metabolic diseases.
✔ Mentoring the next generation of medical professionals and researchers.
✔ Contributing to global guidelines on hypertension and cardiovascular risk management.

Her dedication to patient care, research, and teaching makes her an influential figure in modern internal medicine and hypertension research.

🌟CONCLUSION :

Assist. Prof. Dr. Christina Antza is a dedicated clinician, researcher, and educator in the fields of hypertension, metabolic syndrome, and internal medicine. With a strong academic foundation, international research collaborations, and numerous accolades, she continues to advance medical knowledge and improve patient care. Her contributions to medical education and research have made a lasting impact, inspiring future generations of physicians. As she progresses in her career, Dr. Antza remains committed to innovation, scientific discovery, and excellence in healthcare, shaping the future of cardiovascular and metabolic disease management. Her work stands as a testament to dedication and expertise.

TOP NOTABLE PUBLICATIONS

Clinic, Ambulatory and Home Blood Pressure Monitoring for Metabolic Syndrome: Time to Change the Definition?

Journal: Medicina

Year: 2025

The Microbial Perspective: A Systematic Literature Review on Hypertension and Gut Microbiota

Journal: Nutrients

Year: 2024

The Effects of Olive Oil Consumption on Biochemical Parameters and Body Mass Index of People with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Journal: Nutrients

Year: 2024

Familial Hypercholesterolemia in the Elderly: An Analysis of Clinical Profile and Atherosclerotic Cardiovascular Disease Burden from the Hellas-FH Registry

Journal: Biomedicines

Year: 2024

The Modern Environment: The New Secondary Cause of Hypertension?

Journal: Medicina

Year: 2023

The Importance of Out-of-Office Blood Pressure Measurement, as Highlighted by the Correlation with Left Ventricular Hypertrophy in an Untreated Hypertensive Population

Journal: Medicina

Year: 2023

QIU SUN | Vascular disease | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Mr. QIU SUN | Vascular disease | Best Researcher Award

Mr. QIU SUN, Heilongjiang University of Chinese Medicine, China

Mr. Qiu Sun is the Director of the Department, Chief Physician, Associate Professor, and a Ph.D. candidate at Heilongjiang University of Chinese Medicine, China. A recognized expert in Traditional Chinese Medicine (TCM), he is a National Academic Successor and policy advisor in TCM healthcare. He has led multiple research projects, published SCI-indexed papers, and contributed to national textbooks. With two invention patents and numerous awards, he plays a key role in TCM education, clinical practice, and policy-making. His work focuses on integrative medicine, vascular diseases, and external treatments, making a significant impact on TCM’s modernization and global recognition.

AUTHOR PROFILE

Scopus Profile

🎓 EARLY ACADEMIC PURSUITS:

Mr. Sun Qiu was born in June 1982 and pursued his medical education at Heilongjiang University of Chinese Medicine, graduating in June 2009. His academic journey in Traditional Chinese Medicine (TCM) was marked by dedication to both theoretical and clinical practice. Currently, he is a Ph.D. candidate, continuously expanding his expertise in integrative medicine while mentoring future medical professionals as a Master’s Supervisor.

🏥 PROFESSIONAL ENDEAVORS:

As the Director of the Department, Chief Physician, and Associate Professor, Sun Qiu plays a crucial role in shaping TCM medical practices. His extensive responsibilities include supervising medical teams, enhancing healthcare quality, and pioneering innovative treatment methodologies. His leadership has significantly contributed to policy development in TCM hospitals across Heilongjiang Province.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON VASCULAR DISEASE:

Mr. Sun Qiu has been actively involved in various high-impact research projects, including:

  • Principal Investigator for 1 provincial-level project, 3 department-level projects, and 2 university-level projects
  • Participant in a National Natural Science Foundation of China (NSFC) project
  • Published 2 SCI-indexed papers and over 20 other research papers
  • Editor, co-editor, or contributor to 8 published books, exceeding 700,000 words
  • Holds 2 invention patents, reflecting his innovative contributions to TCM

His research primarily focuses on integrated traditional Chinese and Western medicine surgery, vascular diseases, and external treatment techniques in TCM.

🌍 IMPACT AND INFLUENCE:

Mr. Sun Qiu’s influence extends beyond clinical practice into policy-making and education. His key roles include:

  • National Academic Successor of Key Clinical Specialties in TCM
  • Expert in the Traditional Chinese Medicine Policy Think Tank
  • National Expert for the Supervision of TCM Statistical Data Quality
  • Project Review Expert for Science and Technology Departments in Sichuan, Anhui, and Guangxi Provinces

His editorial contributions to the “14th Five-Year Plan” National Textbook showcase his commitment to shaping the future of TCM education.

📚 ACADEMIC CITES & JOURNAL CONTRIBUTIONS:

Mr. Sun Qiu is an esteemed peer reviewer for international and national journals, including:

  • Scientific Reports (UK)
  • BMC Gastroenterology
  • Clinical Epigenetics
  • Chinese Health Preservation
  • China Contemporary Medicine

His role as a reviewer ensures high-quality research in TCM and integrative medicine.

🏆 LEGACY AND FUTURE CONTRIBUTIONS:

Mr. Sun Qiu has received numerous prestigious awards, including:

  • Second Prize from the Heilongjiang Provincial Government
  • First Prize from the Heilongjiang Administration of Traditional Chinese Medicine
  • Advanced Individual of the National TCM Monitoring and Statistics Expert Advisory Committee
  • Outstanding Communist Party Member
  • Excellence in Teaching & Advanced Educator Awards

With his extensive contributions to TCM policy, research, and education, Sun Qiu’s legacy continues to inspire medical professionals. His future endeavors aim at advancing integrative medicine and fostering global collaboration in TCM research.

🌟 CONCLUSION:

Mr. Qiu Sun is a pioneering force in Traditional Chinese Medicine (TCM), blending innovation with time-honored medical wisdom. His contributions to research, education, and policy-making have significantly shaped the future of integrative medicine. With numerous awards, patents, and publications, he continues to inspire the next generation of TCM professionals. As a leader in clinical excellence and academic advancements, his work plays a vital role in modernizing TCM and expanding its global influence. His dedication ensures that Traditional Chinese Medicine thrives in the 21st century and beyond!

TOP NOTABLE PUBLICATION

The association between serum copper concentration and prevalence of diabetes among US adults with hypertension (NHANES 2011–2016)

Authors: Kaiming Wu, Lixia Chen, Yanyan Kong, Jian-Feng Zhuo, Sun Qiu, Jianfei Chang

Journal: Journal of Cellular and Molecular Medicine

Year: 2024

Yan Zhang | Cardiovascular diseases | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Yan Zhang | Cardiovascular diseases | Best Researcher Award 

Prof. Yan Zhang, Affiliated Hospital,Liaoning University of Traditional Chinese Medicine, China

Prof. Yan Zhang is a distinguished researcher and medical expert at the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, China. With extensive experience in Traditional Chinese Medicine (TCM), her research focuses on integrative medicine, herbal formulations, and their clinical applications. She has contributed significantly to the advancement of TCM through numerous publications and collaborative projects. Prof. Zhang is dedicated to bridging modern medical practices with ancient healing traditions, enhancing patient care and treatment efficacy. Her work plays a crucial role in promoting evidence-based TCM approaches for various health conditions, fostering innovation in holistic healthcare solutions.

AUTHOR PROFILE

Scopus Profile

✨ EARLY ACADEMIC PURSUITS:

Prof. Yan Zhang embarked on an illustrious academic journey in Traditional Chinese Medicine (TCM). His foundational education began at Liaoning College of Traditional Chinese Medicine, where he earned a Bachelor’s Degree in Traditional Chinese Medicine (1978-1983). His keen interest in advancing his expertise led him to pursue a Master’s Degree in Typhoid Fever (1986-1989) from the same institution. Determined to further his knowledge, he obtained a Ph.D. in Internal Medicine (2001-2004) from Beijing University of Chinese Medicine, one of China’s most prestigious institutions for TCM studies.

👩‍🎓 PROFESSIONAL ENDEAVORS:

Prof. Zhang’s professional career spans over four decades, marked by dedication and leadership. His significant roles include:

  • Chief Physician (Since 2012): He has been leading the Cardiopulmonary Department at the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine.
  • Director of the Department of Research (2006-2012): At the same hospital, he oversaw groundbreaking medical research and contributed to numerous advancements in TCM.
  • Director of Internal Medicine (1989-2001): He served as the Director of the Department of Traditional Chinese Medicine Internal Medicine at the Liaoning College of Traditional Chinese Medicine Affiliated Hospital.
  • Early Medical Practice (1983-1986): His career began as a Doctor in the Department of Internal Medicine at Dandong City Traditional Chinese Medicine Hospital.

📚 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR DISEASES:

Prof. Zhang is a pioneer in Traditional Chinese Medicine, with a specialized focus on cardiovascular diseases. His research revolves around integrating modern medical techniques with traditional healing practices, making significant strides in the treatment of cardiopulmonary disorders. As an academic leader of China’s national key discipline for cardiovascular research, he has spearheaded numerous studies and projects that have influenced the field profoundly.

He is an expert evaluator for major scientific organizations, including:

  • China’s National Natural Science Foundation Projects
  • China’s National Science and Technology Awards

His contributions have been instrumental in shaping national policies and advancements in TCM research.

🌟 IMPACT AND INFLUENCE:

Prof. Zhang’s influence extends beyond his hospital and university. His expertise has earned him several prestigious accolades, including:

  • Renowned Traditional Chinese Medicine Practitioner of Liaoning Province
  • Outstanding Talent & Expert of Liaoning Province
  • Advanced Scientific and Technological Worker in Liaoning Province
  • Recipient of the Special Allowance of the State Council of China

His mentorship has nurtured numerous doctoral candidates, ensuring that the future of Traditional Chinese Medicine remains in capable hands.

📚 ACADEMIC CITES:

Prof. Zhang’s extensive research and scholarly contributions have been widely cited in various national and international medical journals. His work on cardiovascular health, herbal medicine formulations, and the integration of TCM with modern science has set a benchmark for medical professionals worldwide.

🌟 LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Zhang’s legacy in Traditional Chinese Medicine is monumental. His future contributions aim to:

  • Develop new treatment methodologies that combine Western and Eastern medical practices.
  • Mentor the next generation of TCM practitioners.
  • Influence government health policies for the wider acceptance of TCM in mainstream healthcare.
  • Continue his groundbreaking research on cardiovascular diseases.

As a visionary leader in Traditional Chinese Medicine, Prof. Yan Zhang’s dedication, research, and teachings will continue to shape the medical landscape for generations to come.

✨CONCLUSION:

Prof. Yan Zhang’s dedication to Traditional Chinese Medicine (TCM) continues to shape the future of integrative healthcare. Through her research, clinical expertise, and innovative approaches, she bridges ancient wisdom with modern medical advancements, ensuring better patient outcomes . Her contributions not only enhance TCM’s credibility worldwide but also inspire future generations of practitioners and researchers. With a passion for holistic healing and evidence-based medicine, Prof. Zhang remains a key figure in promoting natural therapies for global health and wellness. Her work stands as a testament to the enduring power of TCM in modern medicine.

TOP NOTABLE PUBLICATION

Mechanism of Ferroptosis in Regulating Chronic Heart Failure and Traditional Chinese Medicine Prevention and Treatment Based on Qi Deficiency and Stagnation: A Review

Journal: Chinese Journal of Experimental Traditional Medical Formulae
Year: 2025

Atsuko Nakayama | Cardiac Rehabilitation | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Atsuko Nakayama | Cardiac Rehabilitation | Best Researcher Award

Lingyan Chen | Cardiovascular Diseases | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Lingyan Chen | Cardiovascular Diseases | Best Researcher Award